RSS
RESEARCH UPDATE
Office-Based Opioid Treatment
Joshua Blum, MD. Dr. Blum, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
Addiction Treatment
CLINICAL UPDATE
Trauma and Addiction
Will Rutland, MD, JD, MPH. Assistant Professor and Psychiatry Clerkship Director, UAB Heersink, School of Medicine, Montgomery Regional Campus. Montgomery, AL.
Dr. Rutland, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
RESEARCH UPDATE
Phenobarbital vs Lorazepam in Alcohol Withdrawal
Barnes Clayton, MD. Dr. Barnes, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
EXPERT Q&A
Integrating Trauma-Informed Care into Addiction Treatment
Lydia Bartholow, DNP, PMHNP, CARN-AP
Medical Director, Central City Concern, Portland, OR. Assistant professor, University of California at San Francisco, San Francisco, CA.
Dr. Bartholow, expert for this educational activity, has no financial relationship(s) with ineligible companies to disclose.
Real-World Alcohol Use Disorder Treatment
Ismene Petrakis, MD
Addiction psychiatrist and professor at Yale School of Medicine. Chief of Mental Health, VA Connecticut Healthcare System, New Haven, CT.
Dr. Petrakis has disclosed that she participated in a study in which she did not receive any compensation from Alkermes apart from medication and Alkermes did not fund the study. Dr. Capurso has reviewed this material and found no evidence of bias pertaining to this educational activity.
Alcohol-Induced Liver Disease
Ramon Bataller, MD
Chief of Hepatology, University of Pittsburgh Medical Center, Pittsburgh, PA.
Dr. Bataller has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Medications for Alcohol Use Disorder: An Overview
Mikveh Warshaw, NP.
Psychiatric mental health nurse practitioner, Community Health Center Inc. and faculty member of Center for Key Populations (CKP) Program, Middletown, CT.
Ms. Warshaw has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
Recommended
